external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus.
Explore the latest updates from the life science industry.

London Biotechnology Show_Register Now.png

HEALTH

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

A first-in-human trial for a tampon-like intravaginal drug delivery platform arrives at a moment when England's newly published Women's Health Strategy is calling for exactly this kind of patient-centred innovation.

Featured Articles.

PHARMA

AI in Science Writing and the Imitation of Understanding

PHARMA

Pharma & Biotech Quality Summit 2026

BIOPROCESSING

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biomanufacturing Facility

BIOTECH

Basecamp Research Launches the Trillion Gene Atlas

PHARMA

Inside Nxera Pharma’s Next-Generation Biopharma Model

HEALTH

Killing Mosquitoes With the Smell of Flowers

BIOTECH

UK Biotech Cyclana Bio is Trying to Understand Endometriosis From the Tissue Up and it's Just Recruited its First Patients

SUSTAINABILITY

Engineering Crops From the Inside Out

BIOTECH

PRISM ALS Sets Out to Improve ALS/MND Drug Discovery

Latest News.

20th May, 2026

01. UK Biotech Cyclana Bio is Trying to Understand Endometriosis From the Tissue Up and it's Just Recruited its First Patients

Cyclana Bio's PEMP study has received NHS ethics approval and begun enrolling women at two UK hospitals. If its tissue-first approach to drug discovery pays off, it could start answering questions that have gone unanswered for decades.

11th May, 2026

02. A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

A first-in-human trial for a tampon-like intravaginal drug delivery platform arrives at a moment when England's newly published Women's Health Strategy is calling for exactly this kind of patient-centred innovation.

5th May, 2026

03. Qureight Appoints Board to Advance AI Imaging for Pulmonary Hypertension Trials

Cambridge-based imaging CRO brings together seven global experts to guide development of non-invasive AI endpoints.

28th April, 2026

04. AviadoBio Bets on Blood-Brain Barrier Technology in Push for One-Time Alzheimer's Treatment

A licensing deal with Apertura Gene Therapy gives the London-based biotech a clinically validated delivery system to pair with its gene-silencing platform, but the hard work is still ahead.